Introduction
In men there is a strong relaConship between androgens and erythropoiesis; however this has not been shown in women. PaCents with congenital adrenal hyperplasia (CAH) if uncontrolled may have high androgen levels and if over treated with glucocorCcoids low androgen levels. Therefore CAH provides a potenCal model to examine the relaConship between androgens and erythropoiesis in women.
Aim of the study was to invesCgate the relaConship between androgens and erythropoiesis in females with CAH.
Methodology
• A retrospecCve analysis of data from two cohorts of CAH paCents.
Cohort 1 comprised CAH women from STH, UK (the training set: n=23) and cohort 2 from NIH, US (the validaCon set: n=53).
• Demographic data, CAH phenotype and medical history was gathered from case notes. Androgen levels and blood counts performed on the same day for every paCent were collected.
• Group differences was assessed by Student's t-test and associaCons between variables with adjustment for confounders by parCal correlaCon.
Results
• Hb levels and Hct were significantly higher in cohort 1 than those in cohort 2 women while there were no group differences in androgen levels or glucocorCcoid treatment dose.
• Elevated Hb and Hct above upper limit of reference were found in 30.4% and 47.8% of women, respecCvely, in cohort 1 compared to <4% of women in cohort 2, although cohort 2 had a higher upper limit of normal.
• Within cohort 1, compared to women with normal Hb levels or Hct, women with raised values had higher androgens, but did not differ in glucocorCcoid treatment dose, stature or BMI.
• Ln testosterone showed significant age-adjusted correlaCons (P<0.001) with Hb (r=0.712) and Hct (r=0.705) in the training set (cohort 1) and validaCon set (cohort 2)
• This correlaCon remained significant aaer further adjustments for CAH status, glucocorCcoid treatment dose and serum creaCnine (Hb: r=0.524; Hct: r=0.466) .
• Hb and Hct correlated less strongly with the androgen precursors androstenedione and 17-OHP.
Conclusions
• There is a posiCve and strong correlaCon between total testosterone and erythropoiesis in women with CAH, which was seen across two different cohorts. There is a weaker but significant correlaCon with androgen precursors.
• SubopCmal control of androgens in this group of paCents may increase the risk of either polycythaemia or anaemia.
• Haemoglobin and haematocrit may be used as addiConal biomarkers of disease control in women with CAH but larger prospecCve studies are necessary to confirm this.
• Baseline characterisCcs did not differ significantly between the two cohorts. Mean age was 35.3 (SD ± 14) years in the cohort 1 and 30.8 (SD ± 11.4) years in the cohort 2.
• Majority of both cohorts had a diagnosis of SW CAH; cohort1 n=13(34%) , cohort 2 n=33 (62.3%). 
Cohort 1 (n = 23) Mean (SD)
Cohort
